Summary
The serum levels of osteocalcin, a 49-amino-acid bone-matrix protein, have been found to be a specific biochemical parameter of bone formation. The aim of our study was to compare the sensitivity of serum osteocalcin levels with that of alkaline phosphatase in the evaluation of patients with primary hyperparathyroidism. In 40 patients with biochemically and histologically confirmed primary hyperparathyroidism, the serum levels of osteocalcin, intact parathyroid hormone, alkaline phosphatase, calcium, phosphorus, and creatinine were determined preoperatively. The serum levels of osteocalcin were elevated in 22 patients (55%), whereas the serum levels of alkaline phosphatase were increased in 18 patients (45%). In 10 patients (25%) the serum levels of osteocalcin, but not those of alkaline phosphatase, were increased, whereas in six patients the activity of alkaline phosphatase was high, but the serum osteocalcin levels were normal. When the biochemical data of the patients with increased serum osteocalcin levels were compared with those of the patients with serum osteocalcin levels within the normal range, the serum levels of intact parathyroid hormone and alkaline phosphatase were significantly increased in the group of patients with elevated serum osteocalcin levels. Our data indicate that serum osteocalcin levels might be a clinically useful additional parameter in the evaluation of patients with primary hyperparathyroidism.
Similar content being viewed by others
Abbreviations
- AP:
-
Alkaline phosphatase
- CA:
-
Calcium
- CREA:
-
Creatinine
- GLA:
-
Gamma-carboxy-glutamic acid
- iPTH:
-
Intact parathyroid hormone
- PH:
-
Phosphorus
- OC:
-
Osteocalcin
- PHPT:
-
Primary hyperparathyroidism
References
Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ (1984) Serum bone GLA protein: a specific parameter for bone formation in postmenopausal osteoporosis. Lancet I:1091–1093
Deftos LJ, Parthemore JG, Price PA (1982) Changes in plasma bone GLA protein during treatment of bone disease. Calcif Tissue Int 34:121–124
De la Piedra C, Toural V, Rapado A (1987) Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy. Scand J Clin Lab Invest 47:587–592
Delmas PD, Demiaux B, Malaval L, Chapuy MC, Edouard C, Meunier PJ (1986) Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. J Clin Invest 77:985–991
Delmas PD, Malaval L, Arlot ME, Meunier PJ (1985) Serum bone Gla-protein compared to bone histomorphometry in endocrine diseases. Bone 6:339–342
Fishman WH (1974) Perspectives on alkaline phosphatase isoenzymes. Am J Med 56:617–650
Garcia-Carrasco MG, Gruson M, De Vernejoul MC, Denne MA, Miravet L (1988) Osteocalcin and bone morphometric parameters in adult without bone disease. Calcif Tissue Int 42:13–17
Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valorta C, Mazzuoli G (1988) Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Mineral Electrolyte Metab 14:201–207
Papapoulos SE, Frohlich M, Mudde AH, Harnick HIJ, Berg HVD, Bijvoet OLM (1987) Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment. J Clin Endocrinol Metab 65:89–94
Pietschmann P, Woloszczuk W, Panzer S, Kyrle P, Smolen J (1988) Decreased serum osteocalcin levels in phenprocoumon-treated patients. J Clin Endocrinol Metab 66:1071–1074
Price PA, Parthemore JG, Deftos LJ (1980) New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 66:878–883
Stepan JJ, Presl J, Broulik P, Pacovsky V (1987) Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism. J Clin Endocrinol Metab 64:1079–1082
Torres R, de la Piedra C, Rapado A (1989) Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis. Scand J Lab Invest 49:279–285
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pietschmann, P., Niederle, B., Anvari, A. et al. Serum osteocalcin levels in primary hyperparathyroidism. Klin Wochenschr 69, 351–353 (1991). https://doi.org/10.1007/BF02115782
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02115782